Showing results (121-130 of 595) with videos related to

Sort By:
Pageof 60
Metabolism: Clinical and Experimental|November 24, 1998
Plasma cortisol responses after intramuscular corticotropin 1-24 in healthy menC A Longui, A Vottero, A G Harris, et al.
The Journal of Clinical Investigation|August 1, 1993
Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovaryG Mastorakos, E L Webster, T C Friedman, et al.
Annals of the New York Academy of Sciences|December 29, 1995
Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugsP W Gold, J Licinio, M L Wong, et al.
Annals of the New York Academy of Sciences|November 30, 1994
Glucocorticosteroid resistance in humans. Elucidation of the molecular mechanisms and implications for pathophysiologyC A Stratakis, M Karl, H M Schulte, et al.
Hormone Research|July 1, 1982
Late-onset 21-hydroxylase deficiency is an allelic variant of congenital adrenal hyperplasia characterized by attenuated clinical expression and different HLA haplotype associationsG P Chrousos, D L Loriaux, D Mann, et al.
Endocrinology|February 1, 1986
Steroid-binding proteins in primate plasmaW Rosner, M M Pugeat, G P Chrousos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency?D A Papanicolaou, C Tsigos, E H Oldfield, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndromeM T Gomez, M A Magiakou, G Mastorakos, et al.
Steroids|February 1, 1996
Distribution of hippocampal mineralocorticoid and glucocorticoid receptor mRNA in a glucocorticoid resistant nonhuman primateE O Johnson, L Brady, P W Gold, et al.
The American Journal of the Medical Sciences|September 1, 1989
Interaction of RU 486, a glucocorticoid and progestin antagonist with human circulating mononuclear leukocytesS Kawai, D D Brandon, D L Loriaux, et al.
Pageof 60